A biomedical startup with 100 years of experience

GeneSys Bio was born from thegroup’s many years of experience in both diagnostic-medical and medical device development.

The “biotechteam has gained more than 50 years of experience in rapid diagnostics and molecular biology test development.

The “device” team, more than 65 years strong in the industry, helps develop reliable, low-maintenance and affordable products.

GeneSys Bio logo

Our team

Infectious diseases, oncology, applied engineering, business and marketing.

More than 10 patents, more than 30 scientific publications.

The background of our team has in its diversity its greatest strength.

The experience accumulated over time by each of GeneSys Bio’s members is poured into the project, bringing added value to each of its steps.

Andrea Faviere

Andrea Faviere

CEO

MBA-EMBA LS COMPANY MANAGEMENT
10 YEARS IN BD, MKTG & SALES

Henry Di Oto

Henry Di Oto

COO | Investor Relations

BS, MD, PHD 18 YEARS IN HOSPITAL DIAGNOSIS ENTREPRENEUR

Simone Di Giacomo

Simone Di Giacomo

CSO

BS, PHD > 15 YEARS IN ACADEMIC & CORPORATE R&D

Luciano Ranieri

Luciano Ranieri

CTO

50 YEARS IN MEDICAL DEVICE AND DEVICE DEVELOPMENT

Andrea Faviere

CEO

MBA-EMBA LS COMPANY MANAGEMENT
10 YEARS IN BD, MKTG & SALES

Henry Di Oto

COO | Investor Relations

BS, MD, PHD 18 YEARS IN HOSPITAL DIAGNOSIS ENTREPRENEUR

Simone Di Giacomo

CSO

BS, PHD > 15 YEARS IN ACADEMIC & CORPORATE R&D

Luciano Ranieri

CTO

50 YEARS IN MEDICAL DEVICE AND DEVICE DEVELOPMENT

Those who believe in our project:

OaCP - Oncology and Cytogenetic Products - Fast Laboratory Diagnostics

OaCP IE Ltd

Company leader in rapid diagnostics has chosen GeneSys Bio for its capabilities to implement infection monitoring.

CDP - Cassa Depositi e Prestiti Logo

Cassa Depositi e Prestiti

Cassa Depositi e Prestiti is theItalian National Promotion Institute. Chose to invest in GeneSys Bio, believing it to be a valuable tool for improving healthcare through innovation

AC75 Startup Accelerator - Marche Foundation

AC75 Startup Accelerator

GeneSys Bio was chosen by AC75, a Silver Economy-focused institution and the first of its kind in Europe, after careful evaluation of the team’s skills and the impact the project will have on the target population.